It’s been a tough two days for the drug and device industry.

Yesterday, Wyeth v. Levine.

Today, the Medical Device Safety Act of 2009, which is meant to reverse legislatively the Supreme Court’s pro-preemption decision in Riegel v. Medtronic.

Here’s a link to the House Committee on Energy and Commerce, which reports on the introduction of the MDSA in both the House and the Senate.